Stopper fragments in parenteral preparations: a potential problem
DOI:
https://doi.org/10.26694/repis.v8i.2219Palabras clave:
Drug Contamination, Drug Packaging, Rubber, Patient Safety, Medication ErrorResumen
Introduction: The presence of extrinsic particles in injectable solutions is a medication error of usual occurrence that may has important clinical significance. This study aimed to evaluate the presence of stopper fragments in solution derived from bottle-vial after the preparation of drugs using different sorts of needles. Outline: Experimental study, wherein 50 bottles-vials were used, divided into groups. Group 1: stopper perforated with three-bevel tip needle; Group 2: stopper perforated with blunt tip needle; Group 3: without perforation of the stopper. The figure and the size of the particles were determined through optic microscopy. The data were analyzed by means of descriptive statistics and the differences among the groups were analyzed through Fischer’s Exact Test. Results: It was verified the presence of six stopper fragments in the solution derived from five bottles which had the stoppers perforated by three-bevel tip needle (29.4%) and the two fragments in two bottles which had the stoppers perforated with blunt tip needle (11.8%), with significant difference (p=0.044) in the comparison among the groups. The three-bevel tip needle produces larger particles (0.36 mm2) than then blunt tip needle (0.12mm²). Implications: Risk evaluations must enable the limitation, the detection, and the rejection of atypical unities at the time of the drugs’
preparations, preserving patient safety.
Citas
Anacleto TA, Rosa MB, Neiva HM, Martins MAP. Farmácia Hospitalar. Erros de Medicação. Pharmacia Brasileira. 2010 [cited 2021 feb 15]; 74:24. Available from: http://www.cff.org.br/sistemas/geral/revista/pdf/124/encarte_farmaciahospitalar.pdf
Agência Nacional de Vigilância Sanitária. Glossário da Resolução RDC Nº 04/2009 – Anvisa. De acordo com a RESOLUÇÃO - RDC Nº 4, de 10 de fevereiro de 2009. [cited 2021 jan. 28]. Available from: http://portal.anvisa.gov.br/documents/33868/2894051/Gloss%C3%A1rio+da+Resolu%C3%A7%C3%A3o+RDC+n%C2%BA+4%2C+de+10+de+fevereiro+de+2009/61110af5-1749-47b4-9d81-ea5c6c1f322a
Ambwani S, Misra AK, Kumar R. Medication Errors: is it the hidden part of the submerged iceberg in our Health-care System? Int J Appl Basic Med Res. 2019 [cited 2021 feb 15]; 9(3):135-142. Available from: https://doi.org/10.4103/ijabmr.IJABMR_96_19
Roth JV. How to enter a medication vial without coring. Anesth Analg. 2007 [cited 2021 feb 15]; 104(6):1615. Available from: https://doi.org/10.1213/01.ane.0000260552.76585.53
Patel J, Smith CC. Vial Coring. Pain Med. 2019 [cited 2021 feb 15]; 20(9):1841-2. Available from: https://doi.org/10.1093/pm/pnz132
Mathonet S, Mahler HC, Esswein ST, Mazaheri M, Cash PW, Wuchner K, et al. A biopharmaceutical industry perspective on the control of visible particles in biotechnology-derived injectable drug products. PDA J Pharm Sci Technol. 2016 [cited 2021 feb 15]; 70(4):392-408. Available from: https://doi.org/10.5731/pdajpst.2015.006189
Kordi R, White BF, Kennedy DJ. Possibility and risk of medication vial coring in Interventional Spine Procedures. PM R. 2017 [cited 2021 feb 15]; 9(3):289-93. Available from: https://doi.org/10.1016/j.pmrj.2016.09.003
Doessegger L, Mahler HC, Szczesny P, Rockstroh H, Kallmeyer G, Langenkamp A, et al. The potential clinical relevance of visible particles in parenteral drugs. J Pharm Sci. 2012 [cited 2021 feb 15]; 101(8):2635-44. Available from: https://doi.org/10.1002/jps.23217
Langille SE. Particulate matter in injectable drug products. PDA J Pharm Sci Technol. 2013 [cited 2021 feb 15]; 67(3):186-200. Available from: https://doi.org/10.5731/pdajpst.2013.00922
Heiss-Harris GM, Verklan MT. Maximizing patient safety: filter needle use with glass ampules. J Perinat Neonatal Nurs. 2005 [cited 2021 feb 15];19(1):74-81. Available from: https://insights.ovid.com/pubmed?pmid=15796427
Agência Nacional de Vigilância Sanitária. Farmacopeia Brasileira. Brasília: Anvisa; 2019 [cited 2021 feb. 18]. Available from: http://portal.anvisa.gov.br/documents/33832/259143/Volume+I+Pronto.pdf/4ff0dfe8-8a1d-46b9-84f7-7fa9673e1ee1
Borchert SJ, Abe A, Aldrich DS, Fox LE, Freeman JE, White RD. Particulate matter in parenteral products: a review. J Parenter Sci Technol. 1986 [cited 2021 feb 15]; 40(5):212-41. Available from: https://journal.pda.org/content/40/5/212
Riess ML, Strong T. Near-embolization of a rubber core from a propofol vial. Anesth Analg. 2008 [cited 2021 feb 15]; 106(3):1020-1. Available from: https://doi.org/10.1213/ane.0b013e31816323b4
Gragasin FS, van den Heever ZA. The incidence of propofol vial coring with blunt needle use is reduced with angled puncture compared with perpendicular puncture. Anesth Analg. 2015 [cited 2021 feb 15]; 120(4):954-5. Available from: https://doi.org/10.1213/ANE.0000000000000599
Lehr HA, Brunner J, Rangoonwala R, Kirkpatrick CJ. Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle. Am J Respir Crit Care Med. 2002 [cited 2021 feb 15]; 165(4):514-20. Available from: https://www.atsjournals.org/doi/full/10.1164/ajrccm.165.4.2108033?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed
Gomes M, Romcy H. Economic evaluation of the use of pre-filled syringe versus manually filled syringe paraflushing in patients with central venous cateter in the perspective of health careers. J Bras Econ Saúde. 2018 [cited 2021 feb 15]; 10(3):239-45. Available from: https://doi.org/10.21115/JBES.v10.n3.p239-45
Wani T, Wadhwa A, Tobias JD. The incidence of coring with blunt versus sharp needles. J Clin Anesth. 2014 [cited 2021 feb 15]; 26(2):152-4. Available from: https://doi.org/10.1016/j.jclinane.2013.10.007
Campagna R, Pessis E, Guerini H, Feydy A, Drapé JL. Occurrence of coring after needle insertion through a rubber stopper: study with prednisolone acetate. Eur Radiol. 2013 [cited 2021 feb 15]; 23(2):424-7. Available from: https://doi.org/10.1007/s00330-012-2602-3
Heitz JW, Bader SO. An evidence-based approach to medication preparation for the surgical patient at risk for latex allergy: is it time to stop being stopper poppers? J Clin Anesth. 2010 [cited 2021 feb 15]; 22(6):477-83. Available from: https://doi.org/10.1016/j.jclinane.2009.12.006
Chennell P, Bourdeaux D, Citerne Q, Arnaud C, Cosserant S, Boiko-Alaux V, et al. Rubber coring of injectable medication vial stoppers: an evaluation of causal factors. Pharm Technol Hosp Pharm. 2016 [cited 2021 feb 15]; 1(4):165-174. Available from: https://doi.org/10.1515/pthp-2016-0015
Johns J, Golfetto P, Bush T, Fantozzi G, Shabushnig J, Perry A, et al. Achieving "Zero" defects for visible particles in injectables. PDA J Pharm Sci Technol. 2018 [cited 2021 feb 15]; 72(6):640-50. Available from: https://doi.org/10.5731/pdajpst.2018.009027
